161 related articles for article (PubMed ID: 38658426)
21. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
[TBL] [Abstract][Full Text] [Related]
22. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
[TBL] [Abstract][Full Text] [Related]
24. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
[TBL] [Abstract][Full Text] [Related]
25. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
Huang JR; Shen HC; Sun CY; Chen WC; Chen YM; Feng JY; Yang KY
J Formos Med Assoc; 2022 Dec; 121(12):2617-2625. PubMed ID: 35953342
[TBL] [Abstract][Full Text] [Related]
26. Early versus late tracheostomy in critically ill COVID-19 patients.
Szafran A; Dahms K; Ansems K; Skoetz N; Monsef I; Breuer T; Benstoem C
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015532. PubMed ID: 37982427
[TBL] [Abstract][Full Text] [Related]
27. COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes.
de Almeida JN; Doi AM; Watanabe MJL; Maluf MM; Calderon CL; Silva M; Pasternak J; Koga PCM; Santiago KAS; Aranha LFC; Szarf G; da Silva Teles GB; Filippi RZ; Paes VR; Baeta M; Hamerschlak N; Mangueira CLP; Martino MDV
Mycoses; 2022 Apr; 65(4):449-457. PubMed ID: 35174567
[TBL] [Abstract][Full Text] [Related]
28. COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020-March 2021.
Sivasubramanian G; Ghanem H; Maison-Fomotar M; Jain R; Libke R
J Fungi (Basel); 2021 Nov; 7(11):. PubMed ID: 34829235
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
[TBL] [Abstract][Full Text] [Related]
31. Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant.
Wang Y; Yao Y; Zhang Q; Chen H; He Y; Hu K
BMC Infect Dis; 2024 Jan; 24(1):117. PubMed ID: 38263011
[TBL] [Abstract][Full Text] [Related]
32. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
Hurt W; Youngs J; Ball J; Edgeworth J; Hopkins P; Jenkins DR; Leaver S; Mazzella A; Molloy SF; Schelenz S; Wise MP; White PL; Yusuff H; Wyncoll D; Bicanic T
Thorax; 2023 Dec; 79(1):75-82. PubMed ID: 37657925
[TBL] [Abstract][Full Text] [Related]
33. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.
Leistner R; Schroeter L; Adam T; Poddubnyy D; Stegemann M; Siegmund B; Maechler F; Geffers C; Schwab F; Gastmeier P; Treskatsch S; Angermair S; Schneider T
Crit Care; 2022 Jan; 26(1):30. PubMed ID: 35090528
[TBL] [Abstract][Full Text] [Related]
35. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
[TBL] [Abstract][Full Text] [Related]
36. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
37. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
[TBL] [Abstract][Full Text] [Related]
38. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
[TBL] [Abstract][Full Text] [Related]
39. Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024.
de Prost N; Audureau E; Guillon A; Handala L; Préau S; Guigon A; Uhel F; Le Hingrat Q; Delamaire F; Grolhier C; Tamion F; Moisan A; Darreau C; Thomin J; Contou D; Henry A; Daix T; Hantz S; Saccheri C; Giordanengo V; Pham T; Chaghouri A; Bay P; Pawlotsky JM; Fourati S;
Ann Intensive Care; 2024 Jun; 14(1):101. PubMed ID: 38940865
[TBL] [Abstract][Full Text] [Related]
40. Comparison of clinical outcomes in critically ill COVID-19 patients on mechanical ventilation with nosocomial pneumonia between Alpha and Omicron variants.
Sun CY; Huang JR; Shen HC; Liao YT; Ko HJ; Chang CJ; Chen YM; Feng JY; Chen WC; Yang KY
Ther Adv Respir Dis; 2023; 17():17534666231213642. PubMed ID: 38018405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
